anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (FITC)
Code | Size | Price |
---|
ANC-275-040-120tests | 120 tests | £332.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Target Species: Human
Applications:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Flow Cytometry
Shipping:
BI
Storage:
4°C
Documents
Further Information
Alternate Names/Synonyms:
BAFF-R; BAFF Receptor; BR3; BlySR3; Tumor Necrosis Factor Receptor Superfamily Member 13C; TNFRSF13C
EClass:
32160000
Form (Short):
liquid
Formulation:
50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative).
Handling Advice:
Avoid freeze/thaw cycles.Protect from light.
Immunogen:
Recombinant human CD268.
Labels - Conjugates:
FITC
Long Description:
Monoclonal Antibody. Isotype: Mouse IgG1kappa. Clone: ANC268.2/6E6. Applications: ELISA, FACS. 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 5% Glycerol, 0.2% BSA, 0.04% NaN3 (as a preservative). Three receptors for BAFF were recently identified and designated TACI, BCMA and BAFF-R. BAFF-R signaling is essential for B cell development, survival and humoral immune responses.
Package Type:
Plastic Vial
Product Description:
Three receptors for BAFF were recently identified and designated TACI, BCMA and BAFF-R. BAFF-R signaling is essential for B cell development, survival and humoral immune responses.
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibody Conjugates
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 1 year after receipt when stored at +4°C.
Related Products
Product Name | Product Code | Supplier | anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) | ANC-275-020 | Ancell | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (Biotin) | ANC-275-030 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (R-PE) | ANC-275-050 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
anti-CD268 [BAFF-R] (human), mAb (ANC268.2/6E6) (preservative free) | ANC-275-820 | Ancell | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||